Skip to main navigation Skip to search Skip to main content

Incidence of acute kidney injury in critically ill patients receiving vancomycin with concomitant piperacillin-tazobactam, cefepime, or meropenem

  • University of Kansas Health System
  • Barnes-Jewish Hospital
  • Washington University School of Medicine in St. Louis

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbere02658-18
JournalAntimicrobial Agents and Chemotherapy
Volume63
Issue number5
DOIs
StatePublished - May 2019

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Keywords

  • Acute kidney injury
  • Cefepime
  • Meropenem
  • Piperacillin-tazobactam
  • Vancomycin

Cite this